BreastTrueTM High Risk Panel is a next-generation sequencing test that analyzes 7 high-risk breast cancer genes, including BRCA1, BRCA2, and PALB2. It has a 3-week turnaround time and accepts blood and saliva samples. The test uses sequencing and deletion/duplication analysis to detect mutations in the genes and provides genetic consultations.